secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2023-07-21T23:59:59+00:00
Accession:  0001193125-23-190800
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio closes $40M registered direct offering of common stock and warrants
-------------------------------------------------------------------------------

- Issued 14,569,296 shares at $2.7455 per share with warrants for 14,569,296 shares at $3.2946.
- Gross proceeds of ~$40M before fees; Jefferies as placement agent at 6% fee.
- Warrants are immediately exercisable and expire 3 years from issuance.
- Closing expected July 25, 2023, subject to customary conditions.
- February 2023 warrants amended to match new warrants' exercise price and 3-year term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000119312523190800/0001193125-23-190800-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000119312523190800/d489429d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-190800

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer